ADLM 2024
Tracking # 20-1230884
Price not reported
There are no ratings for this course
Learn moreCourse overview
ADLM 2024 (formerly AACC Annual Scientific Meeting & Clinical Lab Expo) brings together the global laboratory medicine community and provides the latest education to meet the changing needs of laboratory professionals. This conference provides attendees opportunities to connect with global leaders, learn about cutting edge technology, and stay up to date on best practices and advances in laboratory medicine.
Subject areas
This course counts toward the state boards and subject areas below.
American Board of Clinical Chemistry
Clinical Chemistry Diplomate
Molecular Diagnostics Diplomate
Toxicological Chemistry Diplomate
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technologist
Disclosure statements
The faculty, planning committee members, and staff who are in a position to control the content of this activity are required to disclose to ADLM and to learners any financial relationship(s) of the individual that have occurred within the last 24 months with any ACCME-defined ineligible companies. An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are defined by remuneration in any amount from the ineligible companies in the form of honoraria; consulting fees; grants or research support; payments for participation in advisory boards, boards of directors, committees, or speakers’ bureaus; stocks, bonds, other ownership interests; salary; intellectual property or royalties; or other financial benefits. The intent of this disclosure is not to prevent planners with financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. ADLM has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.
The following activity planners reported the following financial relationship(s):
- Allison Chambliss
- Honorarium/Expenses: Cardinal Health
- Consultant Fees, Committee/Board: Roche Diagnostics
- Mari DeMarco
- Honorarium/Expenses: Roche Diagnostics Corporation
- Consultant Fees, Committee/Board: Siemens Healthcare Diagnostics Inc.; Waters Corporation
- Grant/Research Support: Roche Diagnostics Corporation
- Jane Dickerson
- Consultant Fees, Committee/Board: BD
- Joshua Hayden
- Consultant Fees, Committee/Board: BioPorto
- Patrick Kyle
- Honorarium/Expenses: Abbott Diagnostics
- Grant/Research Support: Ark Diagnostics
- Mark Marzinke
- Consultant Fees, Committee/Board: Bio-Rad
- Grant/Research Support: Merck; Gilead; ViiV/GSK
- Jaime Noguez
- Grant/Research Support: Becton Dickinson and Company
- Christina Pierre
- Consultant Fees, Committee/Board: Borderlife Medical Laboratory Trinidad and Tobago
- David Sacks
- Grant/Research Support: Trinity Biotech, Sebia
- IP/Royalty Income: Patent on Anti-Calmodulin Antibody
- William Winter
- Consultant Fees, Committee/Board: Becton-Dickinson
The following activity planners reported no financial relationships:
Darci Block, Saswati Das, Aaron Geno, Edmunds Reineks, Joely Straseski, Clayton Wilburn, and Gabrielle Winston-McPherson.
A summary of all faculty disclosures will be available here. All faculty will display their disclosure information at the beginning of each session, verbally and/or on their presentation slides. Faculty disclosures are also available via the mobile app.
All ADLM staff involved in the planning of this activity reported no financial relationships.